Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Pharmacokinetics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Plasma (human) Chemical Compounds
Tandem Mass Spectrometry Medicine & Life Sciences
temozolomide Medicine & Life Sciences
Liquid chromatography Chemical Compounds
Mass spectrometry Chemical Compounds
Liquid Chromatography Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2018

Muscadine grape skin extract (MPX) in men with biochemically recurrent prostate cancer: A randomized, multicenter, placebo-controlled clinical trial

Paller, C. J. , Zhou, X. C. , Heath, E. I. , Taplin, M. E. , Mayer, T. , Stein, M. N. , Bubley, G. J. , Pili, R. , Hudson, T. , Kakarla, R. , Abbas, M. M. , Anders, N. M. , Dowling, D. , King, S. , Bruns, A. B. , Wagner, W. D. , Drake, C. G. , Antonarakis, E. S. , Eisenberger, M. A. , Denmeade, S. R. & 3 others Rudek, M. A., Rosner, G. L. & Carducci, M. A. Jan 15 2018 In : Clinical Cancer Research. 24, 2, p. 306-315 10 p.

Research output: Contribution to journalArticle

Controlled Clinical Trials
Prostatic Neoplasms

The effect of an adenosine A$$subscript$$2A$atsubscriptat$ agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastoma

Jackson, S., Weingart, J., Nduom, E. K., Harfi, T. T., George, R. T., McAreavey, D., Ye, X., Anders, N. M., Peer, C., Figg, W. D., Gilbert, M., Rudek, M. A. & Grossman, S. A. Jan 15 2018 In : Fluids and Barriers of the CNS. 15, 1, 2

Research output: Contribution to journalArticle

Blood-Brain Barrier

Adaptation to TKI treatment reactivates ERK signaling in tyrosine kinase–driven leukemias and other malignancies

Bruner, J. K., Ma, H. S., Li, L., Qin, A. C. R., Rudek, M. A., Jones, R. J., Levis, M. J., Pratz, K. W., Pratilas, C. A. & Small, D. Oct 15 2017 In : Cancer Research. 77, 20, p. 5554-5563 10 p.

Research output: Contribution to journalArticle

Protein-Tyrosine Kinases
Acute Myeloid Leukemia
Mitogen-Activated Protein Kinase Kinases

A phase 1 study of the PARP inhibitor veliparib in combination with temozolomide in acute myeloid leukemia

Gojo, I. , Beumer, J. H. , Pratz, K. W. , McDevitt, M. A. , Baer, M. R. , Blackford, A. L. , Smith, B. D. , Gore, S. D. , Carraway, H. E. , Showel, M. M. , Levis, M. J. , Dezern, A. E. , Gladstone, D. E. , Ji, J. J. , Wang, L. , Kinders, R. J. , Pouquet, M. , Ali-Walbi, I. , Rudek, M. A. , Poh, W. & 5 others Herman, J. G., Karnitz, L. M., Kaufmann, S. H., Chen, A. & Karp, J. E. Feb 1 2017 In : Clinical Cancer Research. 23, 3, p. 697-706 10 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia

A phase Ib study of sorafenib (BAY 43-9006) in patients with Kaposi sarcoma

Uldrick, T. S., Gonçalves, P. H., Wyvill, K. M., Peer, C. J., Bernstein, W., Aleman, K., Polizzotto, M. N., Venzon, D., Steinberg, S. M., Marshall, V., Whitby, D., Little, R. F., Wright, J. J., Rudek, M. A., Figg, W. D. & Yarchoan, R. May 1 2017 In : Oncologist. 22, 5

Research output: Contribution to journalArticle

Kaposi's Sarcoma
Area Under Curve
Cytochrome P-450 CYP3A